Mendis S, Puska P, Norrving B, editors. Global Atlas on Cardiovascular Disease Prevention and Control. Geneva: World Health Organization; 2011. ISBN 978 92 4 156437 3. http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/
Google Scholar
Global action plan for the prevention and control of noncommunicable diseases 2013–2020. 1. Chronic diseases. 2. Cardiovascular diseases. 3. Neoplasms. 4. Respiratory tract diseases. 5. Diabetes mellitus. 6. Health planning. 7. International cooperation. I.World Health Organization. ISBN 978 92 4 1506236. http://apps.who.int/iris/bitstream/10665/94384/1/9789241506236_eng.pdf. Accessed 25 Oct 2018.
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37(29):2315. https://doi.org/10.1093/eurheartj/ehw106.
Article
PubMed
PubMed Central
Google Scholar
Ordunez P, Prieto-Lara E, Pinheiro Gawryszewski V, Hennis AJM, Cooper RS. Premature Mortality from Cardiovascular Disease in the Americas – Will the Goal of a Decline of “25% by 2025” be Met? PLoS One. 2015;10(10):e0141685. https://doi.org/10.1371/journal.pone.0141685.
Article
CAS
PubMed
PubMed Central
Google Scholar
Younk LM, Lamos EM, Davis SN. The cardiovascular effects of insulin. Expert Opin Drug Saf. 2014;13(7):955–66. https://doi.org/10.1517/14740338.2014.919256 Epub 2014 Jun 5. Review. PubMed PMID: 24899093. http://www.tandfonline.com/doi/abs/10.1517/14740338.2014.919256?journalCode=ieds20.
Article
CAS
PubMed
Google Scholar
Li Y, Li Y, Meng L, Zheng L. Association between serum C-Peptide as a risk factor for cardiovascular disease and high-density lipoprotein cholesterol levels in nondiabetic individuals. PLoS One. 2015;10(1):e112281. https://doi.org/10.1371/journal.pone.0112281 eCollection 2015. PubMed PMID: 25559358; PubMed Central PMCID: PMC4283961. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0112281.
Article
CAS
PubMed
PubMed Central
Google Scholar
Min JY, Min KB. Serum C-Peptide levels and risk of death among adults without diabetes mellitus. CMAJ. 2013;185(9):E402–8. https://doi.org/10.1503/cmaj.121950 Epub 2013 Apr 15. PubMed PMID: 23589428; PubMed Central PMCID: PMC3680586. http://www.cmaj.ca/content/185/9/E402.long.
Article
PubMed
PubMed Central
Google Scholar
Steiner DF, Cunningham D, Spigelman L, et al. Insulin biosynthesis: evidence for a precursor. Science. 1967;157(3789):697–700 http://science.sciencemag.org/content/157/3789/697.long.
Article
CAS
Google Scholar
Hirai FE, Moss SE, Klein BE, Klein R. Relationship of glycemic control, exogenous insulin, and C-Peptide levels to ischemic heart disease mortality over a 16-year period in people with older-onset diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR). Diabetes Care. 2008;31(3):493–7 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773445/.
Article
CAS
Google Scholar
Wahren J, Shafqat J, Johansson J, Chibalin A, Ekberg K, Jornvall H. Molecular and cellular effects of C-Peptide- new perspectives on an old peptide. Exp Diabesity Res. 2004;5(1):15–23 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892072/pdf/125_2010_Article1736.pdf.
Article
CAS
Google Scholar
Walcher D, Babiak C, Poletek P, Rosenkranz S, Bach H, Betz S, Durst R, Grüb M, Hombach V, Strong J, Marx N. C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2. Circ Res. 2006;99(11):1181–7 PubMed PMID: 17068290 http://circres.ahajournals.org/content/99/11/1181.long.
Article
CAS
Google Scholar
Marx N, Walcher D. C-Peptide and Atherogenesis: C-Peptide as a Mediator of Lesion Development in Patients with Type 2 Diabetes Mellitus? Exp Diabesity Res. 2008;2008:385108. https://doi.org/10.1155/2008/385108 5 pages. https://www.hindawi.com/journals/jdr/2008/385108/.
Article
CAS
Google Scholar
Cabrera de Leon A, Oliva Garcia JG, Marcelino Rodriguez I, Almeida Gonzalez D, Aleman Sanchez JJ, Brito Diaz B, et al. C-Peptide as a risk factor of coronary artery disease in the general population. Diab Vasc Dis Res. 2015;12(3):199–207 http://dvr.sagepub.com/content/12/3/199.long.
Article
CAS
Google Scholar
Marx N, Silbernagel G, Brandenburg V, Burgmaier M, Kleber ME, Grammer TB, et al. C-Peptide levels are associated with mortality and cardiovascular mortality in patients undergoing angiography: the LURIC study. Diabetes Care. 2013;36(3):708–14 http://care.diabetesjournals.org/content/36/3/708.
Article
CAS
Google Scholar
Patel N, Taveira TH, Choudhary G, Whitlatch H, Wu WC. Fasting serum C-Peptide levels predict cardiovascular and overall death in nondiabetic adults. J Am Heart Assoc. 2012;1(6):e003152. https://doi.org/10.1161/JAHA.112.003152 PubMed PMID: 23316320; PubMed Central PMCID: PMC3540682 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540682/.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bo S, Gentile L, Castiglione A, Prandi V, Canil S, Ghigo E, et al. C-Peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up. Eur J Endocrinol. 2012;167(2):173–80 https://eje.bioscientifica.com/view/journals/eje/167/2/173.xml.
Article
CAS
Google Scholar
Victora CG, Barros FC. Cohort Profile: The 1982 Pelotas (Brazil) Birth Cohort Study. Int J Epidemiol. 2006;35(2):237–42. https://doi.org/10.1093/ije/dyi290 First published online December 22, 2005. https://academic.oup.com/ije/article/35/2/237/694731.
Article
Google Scholar
Horta BL, Gigante DP, Goncalves H, dos Santos Motta J, Loret de Mola C, Oliveira IO, et al. Cohort Profile Update: https://academic.oup.com/ije/article/44/2/441/753028. Accessed 25 Oct 2018.
Lohman TG, Roche AF, Martorell R, editors. Anthropometric Standardization Reference Manual. Champaign: Human Kinetics Books; 1988. p. 5570.
Google Scholar
C-Peptide Assay Specifications. The 1982 Pelotas (Brazil) Birth Cohort Study. Int J Epidemiol. 2015;44(2):441 Siemens Healthcare Diagnostics Products Ltd. Llanberis, Gwynedd LL 55 4EL United Kingdom. https://www.healthcare.siemens.com/clinical-specialities/diabetes/diabetes-related-assays/clinicalsignificance.
Nazmi A, Oliveira IO, Horta BL, Gigante DP, Victora CG. Lifecourse socioeconomic trajectories and C-reactive protein levels in young adults: findings from a Brazilian birth cohort. Soc Sci Med. 2010;70(8):1229–36. https://doi.org/10.1016/j.socscimed.2009.12.014 PubMed PMID: 20137842; PubMed Central PMCID: PMC2877874. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877874/.
Article
PubMed
PubMed Central
Google Scholar
American Diabetes Association. (2) Classification and diagnosis of diabetes. Diabetes Care. 2015;38(Suppl):S8–S16. https://doi.org/10.2337/dc15-S005 Review. PubMed PMID: 25537714. http://care.diabetesjournals.org/content/diacare/38/Supplement_1/S8.full.pdf.
Article
Google Scholar
Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Atenção ao pré-natal de baixo risco / Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. – Brasília: Editora do Ministério da Saúde, 2012. 318 p.: il. – (Série A. Normas e Manuais Técnicos) (Cadernos de Atenção Básica, n° 32) ISBN978–85–334-1936-0. http://bvsms.saude.gov.br/bvs/publicacoes/cadernos_atencao_basica_32_prenatal.pdf
Andrade RLM, Gigante DP, de Oliveira IO, Horta BL. Conditions of gestation, childbirth and childhood associated with C-peptide in young adults in the 1982 Birth Cohort in Pelotas-RS; Brazil. BMC Cardiovasc Disord. 2017;17(1):181. https://doi.org/10.1186/s12872-017-0613-3 PubMed PMID: 28693499; PubMed Central PMCID: PMC5504841.
Article
PubMed
PubMed Central
Google Scholar
Hoogwerf BJ, Bantle JP, Gaenslen HE, Greenberg BZ, Senske BJ, Francis R, Goetz FC. Infusion of synthetic human C-Peptide does not affect plasma glucose, sérum insulin, or plasma glucagon in healthy subjects. Metabolism. 1986;35(2):122–5 PubMed PMID: 3511350 http://www.sciencedirect.com/science/article/pii/0026049586901113?via%3Dihub.
Article
CAS
Google Scholar
Oskarsson P, Johansson BL, Adamson U, Lins PE. Effects of C-Peptide on insulin-induced hypoglycaemia and its counterregulatory responses in IDDM patients. Diabet Med. 1997;14(8):655–9 PubMed PMID: 9272591. https://onlinelibrary.wiley.com/doi/pdf/10.1002/%28SICI%291096-9136%28199708%2914%3A8%3C655%3A%3AAID-DIA435%3E3.0.CO%3B2-G.
Article
CAS
Google Scholar
Nordquist L, Johansson M. Proinsulin C-Peptide: friend or foe in thedevelopment of diabetes-associated complications? Vasc Health Risk Manag. 2008;4(6):1283–8 Review. PubMed PMID: 19337542; PubMed Central PMCID: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663462/pdf/VHRM-4-1283.pdf.
Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol. 2003;14(3):281–7. Review. PubMed PMID: 12840659. https://doi.org/10.1097/01.mol.0000073508.41685.7f.
Article
CAS
PubMed
Google Scholar
Ertunc ME, Hotamisligil GS. Sinalização lipídica e lipotoxicidade em metaflammation: indicações para patogênese e tratamento da doença metabólica. J Lipid Res. 2016 dez; 57 (12): 2099-2114. Epub 2016 Jun 21. Review. PubMed PMID: 27330055; PubMed Central PMCID: PMC5321214.
Lima NP, Horta BL, Motta JV d S, Valença MS, Oliveira V, dos Santos TV, Gigante DP, Barros FC. Evolução do excesso de peso e obesidade até a idade adulta, Pelotas, Rio Grande do Sul, Brasil, 1982-2012. Cad Saude Publica. 2015;31(9):2017–25. https://doi.org/10.1590/0102-311X00173814.
Article
PubMed
Google Scholar
Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, Goldberg AC, Howard WJ, Jacobson MS, Kris-Etherton PM, Lennie TA, Levi M, Mazzone T, Pennathur S. American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism.; Council on Arteriosclerosis, Thrombosis and Vascular Biology.; Council on Cardiovascular Nursing.; Council on the Kidney in Cardiovascular Disease. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292–333. https://doi.org/10.1161/CIR.0b013e3182160726 PubMed PMID: 21502576. http://circ.ahajournals.org/content/123/20/2292.
Article
Google Scholar
Harchaoui KE, Visser M, Kastelein JJ, Stroes E, Dallinga-Thie G. Triglycerides and Cardiovascular Risk. Curr Cardiol Rev. 2009;5(3):216–22. https://doi.org/10.2174/157340309788970315 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822144/pdf/CCR-5-216.pdf.
Article
CAS
PubMed
PubMed Central
Google Scholar
Galper BZ, Wang YC, Einstein AJ. Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATPIII Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative--Effectiveness Modeling Study. PLoS One. 2015;10(9):e0138092. https://doi.org/10.1371/journal.pone.0138092 PubMed PMID: 26422204; PubMed Central PMCID: PMC4589241. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589241/pdf/pone.0138092.pdf.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23 https://www.sciencedirect.com/science/article/pii/0033062074900346.
Article
Google Scholar
Ridker PM, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation. 2004;109(16):1955–9 PubMed PMID: 15051634 http://circ.ahajournals.org/content/109/16/1955.long.
Article
Google Scholar
Blaha MJ, Budoff MJ, DeFilippis AP, Blankstein R, Rivera JJ, Agatston A, et al. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet. 2011;378:684–92. https://doi.org/10.1016/S0140-6736(11)60784-8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350(14):1387–97 PubMed PMID: 15070788. http://www.nejm.org/doi/full/10.1056/NEJMoa032804.
Article
CAS
Google Scholar
C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC), Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, Shah T, Engert JC, Clarke R, Davey-Smith G, Nordestgaard BG, Saleheen D, Samani NJ, Sandhu M, Anand S, Pepys MB, Smeeth L, Whittaker J, Casas JP, Thompson SG, Hingorani AD, Danesh J. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ. 2011;342:d548. https://doi.org/10.1136/bmj.d548 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039696/.
Article
Google Scholar
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53 PubMed PMID: 15111519. http://care.diabetesjournals.org/content/27/5/1047.full-text.pdf.
Article
Google Scholar
Chen CH, Tsai ST, Chuang JH, Chang MS, Wang SP, Chou P. Population-based study of insulin, C-Peptide, and blood pressure in Chinese with normal glucose tolerance. Am J Cardiol. 1995;76(8):585–8 http://www.sciencedirect.com/science/article/pii/S000291499980160X?via%3Dihub.
Article
CAS
Google Scholar